In vitro antimalarial activity of novel trifluoromethyl- and bis(trifluoromethyl) quinoline derivatives

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 2, 2001, Pages 163-168

  Kgokong, J L ^a   Matsabisa, G M ^a   Breytenbach, J C ^a  

^a UNIVERSITY OF LIMPOPO   (South Africa)

Author keywords

Antimalarial drugs; Trifluoromethyl quinoline derivatives, DNA intercalation, in vitro antimalarial activity

Indexed keywords

2 TRIFLUOROMETHYLQUINOLINE 4 (5 PYRIMIDINO)METHYLENE KETONE DERIVATIVE; 2 TRIFLUOROMETHYLQUINOLINE 4 (N4 ETHYL 5 NITROIMIDAZOLO)METHYLENE KETONE DERIVATIVE; 2,8 BIS(TRIFLUOROMETHYL)QUINOLINE 4 (5 PYRIMIDINO)METHYLENE KETONE DERIVATIVE; 2,8 BIS(TRIFLUOROMETHYL)QUINOLINE 4 (N4 ETHYL 5 NITROIMIDAZOLO)METHYLENE KETONE DERIVATIVE; 8 TRIFLUOROMETHYLQUINOLINE 4 (5 PYRIMIDINO)METHYLENE KETONE DERIVATIVE; 8 TRIFLUOROMETHYLQUINOLINE 4 (N4 ETHYL 5 NITROIMIDAZOLO)METHYLENE KETONE DERIVATIVE; CHLOROQUINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG DNA BINDING; DRUG SENSITIVITY; DRUG STRUCTURE; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM;

EID: 0035117490     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300019     Document Type: Article

References (32)

1. Ferriprotoporphyrin IX binding substances and the mode of action of chloroquine against malaria
2. Malaria Haemozoin/β-haematin supports polymerisation in the absence of protein
3. The mechanism of action of quinolines and related antimalarial drugs
4. High-affinity binding of quinine to iron (11I) porphyrins: Novel formation of alkoxide complexes from alcohols and amines
5. The chemical mechanism of β-haematin formation studied by mössbauer spectroscopy
6. The interaction of the heme-octapeptide - Acetylmicroperoxidase-8 with antimalarial drugs: Solution studies and modelling by molecular mechanics methods
7. Spectroscopic investigations of malaria pigment
8. Lysis of plasmodium falciparum by ferriprotoporphyrin IX and chloroquine-ferriprotopophyrin IX complexes
9. Quinoline anti-malarial drugs inhibit the formation of β-haematin (malaria pigment)
10. Haemozoin and the mode of action of blood schizontocides
11. Inhibition of chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites
12. The heme environment in heme and heme-antimalarial complexes of pharmacological interest
13. Arteether, a new antimalarial drug: Synthesis and antimalarial properties
14. Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum
15. Thermodynamic factors controlling the interaction of quinoline anti-malarial drugs with ferriprotoporphyrin IX
16. Chloroquine resistance not linked to mdr-like genes in plasmodium falciparum
17. The effect of structural changes in a polyamine backbone on its DNA-binding properties
18. Parasite lactate dehydrogenase as an assay for plasmodium falciparum drug sensitivity
19. New 8-(trifluoromethyl)substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxicity
20. Antimalarial drug mefloquine binds to membrane phospholipids
21. Structure and antimalarial activity of aminoalcohols and 2-(p-chlorophenyl)-2-(4-piperidyl)tetrahydrafuran
22. Advances in the preparation of biologically active organofluorine compounds
23. New structure-activity relationship of quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay
24. Spectroscopic studies on the interaction of there partially hydrogenated acridine dyes with calf thymus DNA and their structural comparison
25. Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Assessment of the factors that may determine drug resistance
26. Towards the rational design of antimalarial drugs
27. Reactions between ferriprotoporphyrin IX and the antimalaria endoperoxide artesunate gives an intermediate species with enhanced redox catalytic activity
28. Structural basis of protein-nucleic acid interaction
29. NMR studies on YSPTSPSY: Implication for the design of DNA bisintercalators
30. Quinolones: Structure-activity relationships and future predictions
31. Non-intercalative DNA binding antitumour compounds